收益表 (TTM)
ABVC 生物制药公司 损益表显示一段时间内收入和支出的变化。损益表数据包括销售和收入、毛利、研发、销售、一般和管理费用、经营收入、所得税费用、利息费用、营业外收入、每股收益和已发行股票。
除每股单位外，所有数字都是 1,000,000。
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 收入 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| 改变 （％） | -7.25 | 38.17 | -29.23 | -3.50 | -21.94 | -66.75 | 237.87 | -14.19 | 182.74 | 10.58 | -28.60 | -3.45 | -79.38 | -83.36 | 437.78 | 273.76 | -0.04 | -0.24 | -23.04 | |
| 收入百分比 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| 销售成本 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 改变 （％） | -3.04 | -14.50 | -22.43 | -66.27 | 21.50 | 12.80 | 134.58 | 76.89 | 1,103.12 | 20.37 | 18.74 | 4.61 | -29.47 | -19.85 | -30.07 | -17.32 | -99.45 | -36.30 | -39.09 | |
| 收入百分比 | 3.71 | 3.87 | 2.40 | 2.63 | 0.92 | 1.43 | 4.85 | 3.37 | 6.94 | 29.53 | 32.15 | 53.47 | 57.93 | 198.15 | 954.45 | 124.11 | 27.46 | 0.15 | 0.10 | 0.08 |
| 毛营业利润 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | -0 | -0 | -0 | 0 | 1 | 1 | 0 |
| 改变 （％） | -7.41 | 40.29 | -29.40 | -1.81 | -22.34 | -67.90 | 243.14 | -17.37 | 114.09 | 6.48 | -51.04 | -12.70 | -148.10 | 44.86 | -84.82 | -1,224.38 | 37.59 | -0.18 | -23.03 | |
| 收入百分比 | 96.29 | 96.13 | 97.60 | 97.37 | 99.08 | 98.57 | 95.15 | 96.63 | 93.06 | 70.47 | 67.85 | 46.53 | 42.07 | -98.15 | -854.45 | -24.11 | 72.54 | 99.85 | 99.90 | 99.92 |
| 销售、一般及行政费用 | 5 | 8 | 9 | 9 | 10 | 11 | 16 | 16 | 17 | 13 | 9 | 9 | 7 | 6 | 7 | 6 | 4 | 5 | 3 | 4 |
| 改变 （％） | 81.30 | 2.85 | 4.97 | 5.98 | 14.73 | 40.62 | 0.72 | 10.45 | -24.21 | -32.39 | -2.33 | -16.66 | -22.99 | 20.36 | -10.11 | -28.27 | 16.80 | -41.83 | 45.24 | |
| 收入百分比 | 891.77 | 1,743.20 | 1,297.61 | 1,924.60 | 2,113.75 | 3,106.51 | 13,137.53 | 3,916.12 | 5,040.85 | 1,351.26 | 826.23 | 1,130.35 | 975.62 | 3,643.78 | 26,357.64 | 4,405.71 | 845.57 | 988.01 | 576.10 | 1,087.27 |
| 研发 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| 改变 （％） | -13.57 | 5.19 | 38.01 | 16.16 | 8.30 | 23.72 | 14.00 | 2.97 | 84.75 | -0.91 | -0.69 | -6.19 | -57.25 | -25.02 | -59.48 | -32.04 | -18.32 | -22.43 | -5.12 | |
| 收入百分比 | 122.11 | 113.79 | 86.63 | 168.94 | 203.36 | 282.13 | 1,049.72 | 354.19 | 425.04 | 277.74 | 248.89 | 346.20 | 336.35 | 697.31 | 3,142.38 | 236.78 | 43.05 | 35.18 | 27.35 | 33.72 |
| 运营支出 | 5 | 9 | 9 | 10 | 11 | 12 | 17 | 17 | 19 | 16 | 12 | 12 | 10 | 7 | 8 | 7 | 5 | 5 | 3 | 4 |
| 改变 （％） | 69.61 | 2.96 | 6.98 | 6.71 | 14.16 | 39.20 | 1.74 | 9.88 | -14.32 | -26.17 | -1.35 | -13.54 | -31.68 | 11.63 | -15.83 | -28.45 | 12.10 | -41.16 | 42.95 | |
| 收入百分比 | 1,017.59 | 1,860.87 | 1,386.64 | 2,096.17 | 2,318.04 | 3,390.07 | 14,192.10 | 4,273.68 | 5,472.82 | 1,658.54 | 1,107.27 | 1,530.02 | 1,370.06 | 4,539.24 | 30,454.47 | 4,766.61 | 912.54 | 1,023.34 | 603.55 | 1,121.07 |
| 营业收入 | -5 | -9 | -9 | -9 | -10 | -12 | -17 | -17 | -18 | -15 | -11 | -11 | -9 | -7 | -8 | -6 | -4 | -5 | -3 | -4 |
| 改变 （％） | 77.98 | 0.96 | 9.80 | 7.22 | 15.79 | 42.42 | 0.07 | 10.46 | -17.98 | -28.53 | 1.36 | -14.25 | -27.93 | 13.77 | -17.32 | -34.92 | 13.59 | -45.59 | 56.05 | |
| 收入百分比 | -917.59 | -1,760.87 | -1,286.64 | -1,996.17 | -2,218.04 | -3,290.07 | -14,092.10 | -4,173.68 | -5,372.83 | -1,558.54 | -1,007.27 | -1,430.02 | -1,270.06 | -4,439.24 | -30,354.47 | -4,666.61 | -812.54 | -923.34 | -503.55 | -1,021.07 |
| 利息花费 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -2 | -1 | -1 | -2 | -1 | -1 | -1 | -1 |
| 改变 （％） | 2.33 | -0.32 | -14.33 | 6.47 | -38.30 | -49.30 | -58.96 | 185.82 | 117.53 | 13.08 | 30.08 | 252.56 | -13.83 | 9.52 | 6.42 | -65.26 | 55.27 | 5.00 | -8.96 | |
| 收入百分比 | -76.00 | -83.85 | -60.49 | -73.23 | -80.80 | -63.86 | -97.37 | -11.83 | -39.40 | -30.31 | -31.00 | -56.48 | -206.22 | -861.82 | -5,672.37 | -1,122.47 | -104.34 | -162.07 | -170.58 | -201.80 |
| 净利 | -6 | -10 | -10 | -10 | -10 | -13 | -18 | -18 | -19 | -16 | -12 | -13 | -12 | -8 | -9 | -7 | -4 | -5 | -3 | -4 |
| 改变 （％） | 62.63 | -1.22 | 1.26 | -0.40 | 31.61 | 37.91 | -0.64 | 10.79 | -15.74 | -25.40 | 3.30 | -3.06 | -36.52 | 12.98 | -15.02 | -41.87 | 12.80 | -40.63 | 45.17 | |
| 收入百分比 | -1,155.99 | -2,026.97 | -1,449.21 | -2,073.60 | -2,140.24 | -3,608.46 | -14,965.94 | -4,401.31 | -5,682.74 | -1,693.50 | -1,142.44 | -1,652.99 | -1,659.59 | -5,109.26 | -34,690.51 | -5,482.11 | -852.59 | -962.12 | -572.55 | -1,080.01 |
Source: Capital IQ
